reports
MAIA Biotechnology Announces $736,600 Private Placement
MAIA Biotechnology Announces $736,600 Private Placement CHICAGO, IL, Oct. 13, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 603,769 shares of common stock at a purchase price of $1.22 per share, in a private placement to accredited investors. Each share of common stock is being offered together with a warrant to purchase one share of common s...
MAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused...
MAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused on Top-Tier Crypto Assets MAIA’s Board of Directors authorizes holdings of up to 90% of the Company’s liquid assets in cryptocurrencies (BTC), Ethereum (ETH), and USD Coin (USDC) CHICAGO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced its launch of a new digital asset treasury strategy focused on top-tier cryptocurrency assets. MAIA’s Board of...
Tile Shop’s Board of Directors Approves Plan to Terminate Registration...
Tile Shop’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock MINNEAPOLIS, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (Nasdaq: TTSH) (“Tile Shop” or the “Company”), a specialty retailer of natural stone, man-made and luxury vinyl tiles, setting and maintenance materials and related accessories, today announced that the Independent Transaction Committee (the “Transaction Committee”) of the Board of Directors of the Company (the “Board”) comprised of independent directors has recommended, and the Board has approved, a plan to delist its shares of...
MAIA Biotechnology Announces $2.25 Million Private Placement
MAIA Biotechnology Announces $2.25 Million Private Placement CHICAGO, IL, Sept. 29, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,733,766 shares of common stock at a purchase price of $1.30 per share, in a private placement to accredited investors and a Company director. Each share of common stock is being offered together with a warrant to...
- Jonathan Moreland
WOR WORTHINGTON INDUSTRIES INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
NGL NGL ENERGY PARTNERS LP
MTDR MATADOR RESOURCES COMPANY
FRPT FRESHPET INC
FCN FTI CONSULTING INC.
CDNA CAREDX INC
BUSE FIRST BUSEY CORPORATION
KRNY KEARNY FINANCIAL CORP.
NEXT NEXT BIOMETRICS GROUP ASA
CULP CULP INC.
PBHC PATHFINDER BANCORP INC.
ESP ESPEY MANUFACTURING & ELECTRONICS CORP.
BHB BAR HARBOR BANKSHARES
HAIN THE HAIN CELESTIAL GROUP
MBIN INC.
AROC MERCHANTS BANCORP
ARVN ARCHROCK INC.
BCDA ARVINAS HOLDING
UUU BIOCARDIA
SAVA UNIVERSAL SECURITY INSTRUMENTS INC.
COO CASSAVA SCIENCES
AOUT THE COOPER COMPANIES INC.
ALXO AMERICAN OUTDOOR BRANDS
AMR INC.
OPEN ALX ONCOLOGY HOLDINGS
SMMT ALPHA METALLURGICAL RESOURCES INC
PFBX OPENDOOR TECHNOLOGIES INC.
ABSI SUMMIT THERAPEUTICS INC
RYAN PEOPLES FINANCIAL CORP. (MISSISSIPPI)
MRVL ABSCI CORP
KMPH RYAN SPECIALTY GROUP HLDGS INC
BUKS MARVEL BIOSCIENCES CORP
OBLG KEMPHARM INC
VANI BUTLER NATIONAL CORP
SMRT OBLONG INC
PRAX VIVANI MEDICAL INC
NBBK SMARTRENT INC
NCDL PRAXIS PRECISION MEDICINES INC
BHRB NB BANCORP INC.
CAMP NUVEEN CHURCHILL DIRECT LENDING CORP
SI BURKE HERBERT FINANCIAL SERVICES CORP
JSPR CAMP4 THERAPEUTICS CORPORATION
BDSX SHOULDER INNOVATIONS INC
AMPLITUDE HEALTHCARE ACQUISITION CORP
BIODESIX INC
MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes o...
MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent THIO-101 Phase 2 trial to enroll patients in the U.S. as part of the expansion of the study in third-line treatment for advanced non-small cell lung cancer (NSCLC) CHICAGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, announced today that the National Institutes of Health (NIH) has awarded a $2.3 m...
- Jonathan Moreland
SNPS SYNOPSYS INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
NGL NGL ENERGY PARTNERS LP
MTDR MATADOR RESOURCES COMPANY
FRPT FRESHPET INC
BUSE FIRST BUSEY CORPORATION
ASA ASA
CELC CELCUITY
MBIN MERCHANTS BANCORP
AROC ARCHROCK INC.
CCEL CRYO-CELL INTERNATIONAL
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
ALXO ALX ONCOLOGY HOLDINGS
DLHC DALEIGH HOLDINGS CORP
AMR ALPHA METALLURGICAL RESOURCES INC
OPEN OPENDOOR TECHNOLOGIES INC.
CTO CONSOLIDATED-TOMOKA LAND CO
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
NEXT NEXT CAPITAL
RYAN RYAN SPECIALTY GROUP HLDGS INC
KMPH KEMPHARM INC
BUKS BUTLER NATIONAL CORP
OBLG OBLONG INC
VANI VIVANI MEDICAL INC
RH RESTORATION HARDWARE HOLDINGS INC
SMRT SMARTRENT INC
NBBK NB BANCORP INC.
NCDL NUVEEN CHURCHILL DIRECT LENDING CORP
BHRB BURKE HERBERT FINANCIAL SERVICES CORP
CAMP CAMP4 THERAPEUTICS CORPORATION
SI SHOULDER INNOVATIONS INC
MSTR MICROSTRATEGY INCORPORATED
- Jonathan Moreland
- Jonathan Moreland
MTDR MATADOR RESOURCES COMPANY
ASA ASA
PBHC PATHFINDER BANCORP INC.
NEXT NEXTDECADE
CELC CELCUITY
FGBI FIRST GUARANTY BANCSHARES
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
OPEN OPENDOOR TECHNOLOGIES INC.
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
RYAN RYAN SPECIALTY GROUP HLDGS INC
KMPH KEMPHARM INC
NBBK NB BANCORP INC.
BHRB BURKE HERBERT FINANCIAL SERVICES CORP
CAMP CAMP4 THERAPEUTICS CORPORATION
SI SHOULDER INNOVATIONS INC
- Jonathan Moreland
CDNA CAREDX INC
AROW ARROW FINANCIAL CORP.
ESP ESPEY MANUFACTURING & ELECTRONICS CORP.
BSM BLACK STONE MINERALS LP
PLSE PULSE BIOSCIENCES
DLHC DALEIGH HOLDINGS CORP
CTO CONSOLIDATED-TOMOKA LAND CO
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
HYMC HYCROFT MINING HOLDING CORPORATION
- Jonathan Moreland
SBH SALLY BEAUTY HOLDINGS INC.
PRGO PERRIGO CO. PLC
NVCR NOVOCURE LTD.
KURA KURA ONCOLOGY INC.
GLP GLOBAL PARTNERS LP
FRPT FRESHPET INC
FLDM FLUIDIGM
FCN FTI CONSULTING INC.
CPRX CATALYST PHARMACEUTICALS
CE CELANESE CORPORATION
CDNA CAREDX INC
ASA ASA
AROW ARROW FINANCIAL CORP.
MDU MDU RESOURCES GROUP INC
ADC AGREE REALTY CORPORATION
CECE CECO ENVIRONMENTAL CORP.
ESP ESPEY MANUFACTURING & ELECTRONICS CORP.
BHB BAR HARBOR BANKSHARES
MFIN MEDALLION FINANCIAL CORP.
BSM BLACK STONE MINERALS LP
PLSE PULSE BIOSCIENCES
MLP MAUI LAND & PINEAPPLE CO. INC.
CELC CELCUITY
BRT BRT APARTMENTS
CCEL CRYO-CELL INTERNATIONAL
AEYE AUDIOEYE INC
DLHC DALEIGH HOLDINGS CORP
OPCH OPTION CARE HEALTH INC
SMMT SUMMIT THERAPEUTICS INC
CTO CONSOLIDATED-TOMOKA LAND CO
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
NAUT NAUTILUS BIOTECHNOLOGY INC
ENOV ENOVIS CORPORATION
PFHC PROFRAC HLDG CORP
MLYS MINERALYS THERAPEUTICS INC
PROP PRAIRIE OPERATING CO.
DMA DESTRA MULTI ALTERNATIVE FUND
CAMP CAMP4 THERAPEUTICS CORPORATION
SFD SMITHFIELD FOODS INC.
AFCG AFC GAMMA
HYMC INC.
NIQ HYCROFT MINING HOLDING CORPORATION
NIQ GLOBAL INTELLIGENCE PLC
- Jonathan Moreland
FRPT FRESHPET INC
FLDM FLUIDIGM
FCN FTI CONSULTING INC.
ASA ASA
BHB BAR HARBOR BANKSHARES
MFIN MEDALLION FINANCIAL CORP.
BRT BRT APARTMENTS
SMMT SUMMIT THERAPEUTICS INC
CTO CONSOLIDATED-TOMOKA LAND CO
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
ENOV ENOVIS CORPORATION
DMA DESTRA MULTI ALTERNATIVE FUND
CAMP CAMP4 THERAPEUTICS CORPORATION
MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Pha...
MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today highlighted positive efficacy data from its Phase 2 clinical trial, THIO-101, evaluating ateganosine (THIO) sequenced with the immune checkpoint inhibitor (CPI) cemiplimab (Libtayo®) in patients with advanced non-small cell lung cancer (NSCLC) who had...
MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 I...
MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung Cancer Poster details durability and efficacy of ateganosine (THIO) treatment in non-small cell lung cancer (NSCLC) CHICAGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that an abstract titled “Study of THIO Sequenced with Cemiplimab in 3rd Line Immune Checkpoint Inhibitor-resistant aNSCLC: Improvement in PFS” w...
MAIA Biotechnology Announces Publication of Interim Clinical Data on T...
MAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal Cells CHICAGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that a manuscript detailing developments in its Phase 2 THIO-101 clinical trial was accepted and published in the international peer-reviewed open access scientific journal, , in a special issue, “Cellular Mechanisms of Anti-C...
- Jonathan Moreland
TPVG TRIPLEPOINT VENTURE GROWTH BDC CORP
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
HTH HILLTOP HOLDINGS INC.
FLDM FLUIDIGM
COTY COTY INC. CLASS A
UPS UNITED PARCEL SERVICE INC. CLASS B
ASA ASA
MX MAGNACHIP SEMICONDUCTOR CORP.
ELTP ELITE PHARMACEUTICALS INC
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
MYO MYOMO
EBC EASTERN BANKSHARES INC
SUNS SUNRISE REALTY TRUST
GF THE NEW GERMANY FUND
AFCG INC.
SST AFC GAMMA
STSS INC.
SYSTEM1 INC
SHARPS TECHNOLOGY INC.
- Jonathan Moreland
GLP GLOBAL PARTNERS LP
ASA ASA
TZOO TRAVELZOO
MLP MAUI LAND & PINEAPPLE CO. INC.
MBIN MERCHANTS BANCORP
WU THE WESTERN UNION COMPANY
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
ASAN ASANA
ZIP ZIPRECRUITER
ENOV INC.
OBIO ENOVIS CORPORATION
SMRT ORCHESTRA BIOMED HOLDINGS INC
PROP SMARTRENT INC
BKKT PRAIRIE OPERATING CO.
MDRR BAKKT HOLDINGS INC.
MEDALIST DIVERSIFIED REIT INC.
MAIA Biotechnology Granted European Patent for Next Generation Telomer...
MAIA Biotechnology Granted European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy Cancer-fighting immunosuppressive agents shown to disrupt telomeres and suspend growth of cancer cells CHICAGO , Aug. 13, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that the European Patent Office has decided to grant a patent broadly covering a portfolio of ateganosine-based analogues for telomere-targeting ant...
- Jonathan Moreland
VRTX VERTEX PHARMACEUTICALS INCORPORATED
TFX TELEFLEX INCORPORATED
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
SHBI SHORE BANCSHARES INC.
PNFP PINNACLE FINANCIAL PARTNERS INC.
OPK OPKO HEALTH INC.
NSP INSPERITY INC.
NPO ENPRO INDUSTRIES INC.
MTDR MATADOR RESOURCES COMPANY
MMLP MARTIN MIDSTREAM PARTNERS L.P.
LLY ELI LILLY AND COMPANY
KMPR KEMPER CORPORATION
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
EIG EMPLOYERS HOLDINGS INC.
CNOB CONNECTONE BANCORP INC.
CHTR CHARTER COMMUNICATIONS INC. CLASS A
CHD CHURCH & DWIGHT CO. INC.
CDXS CODEXIS
ARW ARROW ELECTRONICS INC.
AMH AMERICAN HOMES 4 RENT CLASS A
CIVB CIVISTA BANCSHARES
OLN OLIN CORPORATION
ASUR ASURE SOFTWARE INC
BRO BROWN & BROWN INC.
CYRX CRYOPORT INC.
FTV FORTIVE CORP.
CLAR CLARUS CORPORATION
A2H9KJ NEO PERFORMANCE MATERIAL
OSPN ONESPAN
FXNC FIRST NATIONAL CORP. OF VIRGINIA
TROX TRONOX HOLDINGS PLC
MEC MAYVILLE ENGINEERING
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
XRX XEROX HOLDINGS CORPORATION
PINE ALPINE INCOME PROPERTY TRUST
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
LRMR LARIMAR THERAPEUTICS INC
THRY THRYV HOLDINGS
DLHC DALEIGH HOLDINGS CORP
INTA INTAPP INC
PTLO PORTILLOS INC
BRBR BELLRING BRANDS INC
AUB ATLANTIC UNION BANKSHARES CORP
AURX NUO THERAPEUTICS
OI INC.
SIRI OWENS ILLINOIS INC.
XELB SIRIUS XM HLDGS INC NEW
MUSA XCEL BRANDS INC.
LNW METALS USA HOLDINGS CORP.
LIGHT & WONDER INC.
The Tile Shop Reports Second Quarter 2025 Results
The Tile Shop Reports Second Quarter 2025 Results MINNEAPOLIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (Nasdaq: TTSH) (the “Company”), a specialty retailer of natural stone, man-made and luxury vinyl tiles, today announced results for its second quarter ended June 30, 2025. Second Quarter 2025 Summary Net Sales Decreased 3.4%Comparable Store Sales Decreased 3.5% Gross Margin of 64.4%Net Income of $0.4 Million and Adjusted EBITDA of $4.9 MillionNo Debt Outstanding and $27.8 million of Cash at Quarter-End Management Commentary – Cabell Lolmaugh, CEO “We bel...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.